Navigation Links
HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information
Date:7/1/2008

managing risk and protecting privacy. It also establishes a benchmark that can be applied to non-covered entities, such as those providing personal health records (PHRs) to consumers. The HITRUST CSF is crucial to address the concerns of patients, policymakers and others," said Dr. Larry Ponemon, Chairman and founder, Ponemon Institute.

The HITRUST Common Security Framework version 2009 will be available for license later this year. More information on the HITRUST CSF can be found on the company's website at http://www.hitrustalliance.org/csf or by calling (469)-587-2250.

About the HITRUST

The Health Information Trust Alliance (HITRUST) was born out of the belief that information security should be a core pillar of, rather than an obstacle to, the broad adoption of health information systems and exchanges. Security is critical to the broad adoption, utilization of and confidence in health information systems, medical technologies and electronic exchanges of health information. This, in turn, is critical to realizing the related promise of quality improvement and cost containment in America's healthcare system. HITRUST is collaborating with healthcare, business, technology, and information security leaders to establish a certifiable framework that can be used by any and all organizations that create, access, store or exchange personal health and financial information. Beyond the establishment of the first-ever common security framework, HITRUST is also driving adoption and widespread confidence in the framework and sound risk management practices through awareness, education, advocacy and other outreach activities. For more information, visit http://www.hitrustalliance.org.

Media contact:

Mike Breslin

Hill & Knowlton (for HITRUST)

214.683.0379


SOURCE Health Information Trust Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Air Methods Corporation Confirms Mid-Air Collision in Arizona
2. Pennsylvania Department of Health Confirms Fifth Salmonella Case Linked to National Outbreak
3. Perrigo Confirms Filing for Generic Version of VANOS(R)
4. Report confirms increased risk of smoking, substance abuse in bipolar adolescents
5. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
6. Pennsylvania Department of Health Confirms Rabid Kitten Found in Adams County
7. ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
8. Air Methods Corporation Confirms Fatal Accident in Wisconsin
9. New Smoking Cessation Guideline Confirms That Now is the Time to Quit Smoking
10. Study by Texas A&M University-Corpus Christi Confirms Training With Vision Software Enhances Hitting Skills
11. Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...s were more likely to consider change after 30-min... , FRIDAY, Nov. 27 (HealthDay News) -- A progr...why they should stop their dangerous behavior may ...archers have found. , The new study included 18...aired convictions, who were randomly assigned to o...
(Date:11/27/2009)...WNA, BC, Nov. 27 /PRNewswire/ - Uploadable USB ped...me time in wellness. A combination of advanced acc... are solving a long term concern over the accuracy...ately gauge and reward improved participation in a... one of the first wellness suppliers to integrate ...
(Date:11/27/2009)...HESTER, N.Y., Nov. 27 P... provider and fortunately every year, new vaccines...But do all vaccines boost immunity for the same pe...oster shots, needed to keep immunity strong? ,...l of the American Academy of Pediatrics, Michael P...
(Date:11/27/2009)...ling plus low-emission vehicles may reduce future ...AY, Nov. 27 (HealthDay News) -- Encouraging city d...would offer much greater public health benefits th...esearchers have found. , The study compared the...rban land transport scenarios for London, England,...
(Date:11/27/2009)... Multi-purpose bilingual coloring books ...se by the business community to educate - inform p... from Safety issues to Dinosuars to ABC,S and a ho...nt Louis, MO (PRWEB) November 27, 2009 -- Today&rs... toys to keep them busy any hour of the day, but o...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
..., Safety and Efficacy Study of Zolpidem Tartrate S...wakening on an As-Needed Basis , , Evaluation of ...sive Compulsive Disorder , , RICHMOND, Calif., Ma...etary products that address important therapeutic ...
..., Videotape The Silliest Sneeze You,ve Ever Seen F...Little Allergies(R) Allergen Block! , , Contest E....Y., May 21 Do your friends, family, or coworkers...Allergen Block , announce the launch of the first ...
...Procedure doubles odds for intensive care compared... , THURSDAY, May 21 (HealthDay News) -- Babies...livery are nearly twice as likely to be admitted t...ion babies are also more likely to have breathing ...
..., LAS VEGAS, May 21 CPC of America, Inc. (OTC Bul...of its first patent of a synthetic sealant for spe... focused on the development and testing of the Med...on, CPC is focused on the development of its own s...
..., PRINCETON, N.J., May 21 Celator Pharmaceuticals...ch agreement with Cephalon, Inc. (Nasdaq: CEPH )...tion of the application of Celator,s proprietary t...echnology and expertise at Celator beyond our own ...
..., - Bold and innovative marketing campaign will ta...of use and excellent tolerability - , , CORONA, C...in generic and specialty branded pharmaceuticals, ...h symptoms of urge urinary incontinence, urgency, ...
Other Medicine News:Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:If Heads Turn When You Sneeze, Enter the 'Side-Splitting Sneeze Contest' 2Health News:Risk to Baby Rises With Repeat C-Sections 2Health News:Risk to Baby Rises With Repeat C-Sections 3Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 3Health News:Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc. 2Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 2Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 3Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 4
(Date:11/26/2009)...frica, Nov. 26 The 2009 Frost &...in the Generic Pharmaceutical Market is presented ... http://www.newscom.com/cgi-bin/prnh/20081117/FSL... following criteria were used to benchmark Cipla M...h strategy and implementation, degree of innovatio...
(Date:11/25/2009)...25 American Scientific R...is pleased to announce that they have opened a reg...n Shanghai, China. ,, ASR has been able to secu...ay for the development and production of current a...and adults to be distributed and sold globally. C...
(Date:11/25/2009)...5 Hologic, Inc. (Hologic...oper, manufacturer and supplier of premium diagnos...s dedicated to serving the healthcare needs of wom...l Society of North America (RSNA) at McCormick Pla...9 to highlight our new SecurView(®) DX multim...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 1Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 3Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 4Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 1Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 2Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 3Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 4Scientists create metal that pumps liquid uphill 12431 1Scientists create metal that pumps liquid uphill 12431 2Scientists create metal that pumps liquid uphill 12431 3
...ODLANDS, Texas--(BUSINESS WIRE)--Apr 3, 2007 - Rep...nal results of a U.S.,Phase 2 study of Proellex(TM...s of uterine fibroids. This study suggests that,tr...ighly,significant improvement in symptoms associat...erated., Study Details and Results , This 12 week,...
...gs indicate early non-responders unlikely to subse... costs, and may benefit,from earlier change in tre..., 2007 /PRNewswire-FirstCall/,-- New data presente...nia Research (ICOSR) suggest that antipsychotic dr...thought, and,challenge the current schizophrenia t...
Other Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6
Reusable Template
MicroTouch LP (Low Profile) Stabilizer
Precision Stepper
SurePoint™ Stepper/Stabilizer EquipmentTable Mount
Medicine Products: